{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:29:24Z","timestamp":1648603764430},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30973479","81272197"],"award-info":[{"award-number":["30973479","81272197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"High Science & Technology Planning Project of China","award":["2007AA021101"],"award-info":[{"award-number":["2007AA021101"]}]},{"name":"Oversea Collaboration Grant of NSFC","award":["81228010"],"award-info":[{"award-number":["81228010"]}]},{"name":"International Collaboration Program of Universities in Guangdong province","award":["2012gjhz001"],"award-info":[{"award-number":["2012gjhz001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.yrtph.2014.12.022","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T01:38:41Z","timestamp":1421199521000},"page":"285-294","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term toxicity study of rAd5-hTERTC27 in SD rats and Cynomolgus monkeys by intravenous injection"],"prefix":"10.1016","volume":"71","author":[{"given":"Pei-jian","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ming","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-xian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2014.12.022_b0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0010","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1182\/blood.V94.12.3965","article-title":"Gene transfer by adenovectors","volume":"94","author":"Brenner","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.yrtph.2014.12.022_b0015","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.yrtph.2014.12.022_b0020","first-page":"2033","article-title":"Recombinant adenovirus p53 agent injection combined with radiotherapy in treatment of nasopharyngeal carcinoma: a phase II clinical trial","volume":"83","author":"Chen","year":"2003","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.yrtph.2014.12.022_b0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2011.03.021","article-title":"Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma","volume":"307","author":"Chen","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yrtph.2014.12.022_b0030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2014.12.022_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jgm.2698","article-title":"Gene therapy clinical trials worldwide to 2012 \u2013 an update","volume":"15","author":"Ginn","year":"2013","journal-title":"J. Gene Med."},{"key":"10.1016\/j.yrtph.2014.12.022_b0040","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3892\/or.2011.1619","article-title":"Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus","volume":"27","author":"Gong","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yrtph.2014.12.022_b0045","first-page":"125","article-title":"Combination therapy with recombinant adenovirus-p53 injection (rAd-p53) via transcatheter hepatic arterial chemoembolization for advanced hepatic carcinoma","volume":"13","author":"Guan","year":"2005","journal-title":"Shijie Huaren Xiaohua Za Zhi"},{"key":"10.1016\/j.yrtph.2014.12.022_b0050","first-page":"2029","article-title":"Effectiveness of recombinant adenovirus p53 injection on laryngeal cancer: phase I clinical trial and follow up","volume":"83","author":"Han","year":"2003","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.yrtph.2014.12.022_b0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3892\/ol.2013.1470","article-title":"Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice","volume":"6","author":"He","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yrtph.2014.12.022_b0060","doi-asserted-by":"crossref","first-page":"e17076","DOI":"10.1371\/journal.pone.0017076","article-title":"Real-time dynamic imaging of virus distribution in vivo","volume":"6","author":"Hofherr","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.yrtph.2014.12.022_b0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/hum.2006.149","article-title":"Long-term toxicity studies in canine of E10A, an adenoviral vector for human endostatin gene","volume":"18","author":"Huang","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0006-291X(02)03049-8","article-title":"A human TERT C-terminal polypeptide sensitizes HeLa cells to H2O2-induced senescence without affecting telomerase enzymatic activity","volume":"301","author":"Huang","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yrtph.2014.12.022_b0075","first-page":"3226","article-title":"Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells","volume":"62","author":"Huang","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.yrtph.2014.12.022_b0080","first-page":"1","article-title":"Cancer immunotherapy targeting the telomerase reverse transcriptase","volume":"3","author":"Huo","year":"2006","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.yrtph.2014.12.022_b0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yrtph.2014.12.022_b0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156652311796150363","article-title":"Advances and future challenges in adenoviral vector pharmacology and targeting","volume":"11","author":"Khare","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0095","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/104303403321618146","article-title":"The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors","volume":"14","author":"Liu","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00535-005-1566-3","article-title":"Updated treatment approach to hepatocellular carcinoma","volume":"40","author":"Llovet","year":"2005","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.yrtph.2014.12.022_b0105","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/10430349950018364","article-title":"Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo","volume":"10","author":"Muruve","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.cgt.7701038","article-title":"A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide","volume":"14","author":"Ng","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1089\/hum.2005.16.1016","article-title":"Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers","volume":"16","author":"Peng","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.cgt.7700539","article-title":"Intravascular adenoviral agents in cancer patients: lessons from clinical trials","volume":"9","author":"Reid","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1525-0016(02)00017-5","article-title":"Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors","volume":"7","author":"Schiedner","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1006\/mthe.2001.0330","article-title":"Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors","volume":"3","author":"Schnell","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0135","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/hmg\/10.7.677","article-title":"Telomerase and cancer","volume":"10","author":"Shay","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yrtph.2014.12.022_b0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/mthe.2000.0227","article-title":"Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver","volume":"3","author":"Tao","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/PPO.0b013e31816a6058","article-title":"Systemic therapy for hepatocellular carcinoma","volume":"14","author":"Thomas","year":"2008","journal-title":"Cancer J."},{"key":"10.1016\/j.yrtph.2014.12.022_b0150","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.2005.03.6756","article-title":"Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer","volume":"24","author":"Tolcher","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yrtph.2014.12.022_b0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1634\/theoncologist.7-1-46","article-title":"Adenoviral gene therapy","volume":"7","author":"Vorburger","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.yrtph.2014.12.022_b0160","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1089\/hum.2005.16.1014","article-title":"Gendicine: the first commercial gene therapy product","volume":"16","author":"Wilson","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yrtph.2014.12.022_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yrtph.2013.06.004","article-title":"Preclinical safety evaluation of rAd5-hTERTC27 by intravenous injection","volume":"67","author":"Yue","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.12.022_b0170","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcb.22328","article-title":"The influence of innate and pre-existing immunity on adenovirus therapy","volume":"108","author":"Zaiss","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"Suppl.","key":"10.1016\/j.yrtph.2014.12.022_b0175","first-page":"56","article-title":"Progress in cancer therapy of rAd\/p53","volume":"2","author":"Zhang","year":"2004","journal-title":"Ai Zheng Jin Zhan"},{"key":"10.1016\/j.yrtph.2014.12.022_b0180","first-page":"11","article-title":"Study of treatment of advanced hepatobiliary carcinoma in patients with rAd-p53","volume":"3","author":"Zhu","year":"2004","journal-title":"Zhonghua Nei Ke Za Zhi"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230014003444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230014003444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T23:49:47Z","timestamp":1598658587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230014003444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0273230014003444"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2014.12.022","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term toxicity study of rAd5-hTERTC27 in SD rats and Cynomolgus monkeys by intravenous injection","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2014.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}